The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Boston Scientific's share price is $103.19.
Boston Scientific's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $11.79. Hence, Boston Scientific's PS Ratio for today is 8.75.
Warning Sign:
Boston Scientific Corp stock PS Ratio (=8.78) is close to 10-year high of 9.42.
The historical rank and industry rank for Boston Scientific's PS Ratio or its related term are showing as below:
BSX'
s PS Ratio Range Over the Past 10 Years
Min: 2.97 Med: 5.25 Max: 9.42
Current: 8.78
During the past 13 years, Boston Scientific's highest PS Ratio was 9.42. The lowest was 2.97. And the median was 5.25.
BSX's PS Ratio is ranked worse than 80.2% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.93
vs BSX: 8.78
Boston Scientific Corp has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Boston Scientific was 18.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 10.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 9.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.90% per year.
During the past 13 years, Boston Scientific's highest 3-Year average Revenue per Share Growth Rate was 29.00% per year. The lowest was -10.50% per year. And the median was 5.80% per year.
Back to Basics: PS Ratio
Boston Scientific PS Ratio Historical Data
The historical data trend for Boston Scientific's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Boston Scientific's PS Ratio
For the Medical Devices subindustry, Boston Scientific's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's PS Ratio distribution charts can be found below:
* The bar in red indicates where Boston Scientific's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Boston Scientific's Share Price of today is $103.19. Boston Scientific's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.79.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Boston Scientific PS Ratio Related Terms
Thank you for viewing the detailed overview of Boston Scientific's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSX has been successfully added to your 